awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q24650581-355C992E-0E81-4922-948C-57B67235376A
Q24650581-355C992E-0E81-4922-948C-57B67235376A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24650581-355C992E-0E81-4922-948C-57B67235376A
Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts
P2860
Q24650581-355C992E-0E81-4922-948C-57B67235376A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24650581-355C992E-0E81-4922-948C-57B67235376A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
debca1751b6f640a00e61e3e8793e36b839e881e
P2860
Update: adverse event data and revised American Thoracic Society/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection--United States, 2003.